谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

AZD9291 as 1st-Line Therapy for EGFR Mutant NSCLC Patients with Concomitant Pretreatment EGFR T790M Mutation. The AZENT Study

Niki Karachaliou,Daniela Morales-Espinosa,Miguel Angel Molina Vila,Javier Garde,Francisco Baron,Manuel Cobo,Guillermo Lopez-Vivanco,Margarita Majem,Jose Miguel Sanchez,Santiago Viteri,Clara Mayo,Margarida Garcia,Rafael Rosell

JOURNAL OF THORACIC ONCOLOGY（2017）

引用 0|浏览33
暂无评分
关键词
EGFR T790M mutation,AZENT study,AZD9291,EGFR mutant NSCLC
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要